trimethoprim has been researched along with Neutropenia in 49 studies
Trimethoprim: A pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to PYRIMETHAMINE. It is potentiated by SULFONAMIDES and the TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION is the form most often used. It is sometimes used alone as an antimalarial. TRIMETHOPRIM RESISTANCE has been reported.
trimethoprim : An aminopyrimidine antibiotic whose structure consists of pyrimidine 2,4-diamine and 1,2,3-trimethoxybenzene moieties linked by a methylene bridge.
Neutropenia: A decrease in the number of NEUTROPHILS found in the blood.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A total of 63 neutropenic patients receiving cytotoxic therapy for acute leukemia were randomly allocated to receive norfloxacin (400 mg every 12 hours) or cotrimoxazole (160/800 mg every 12 hours) to prevent bacterial infection." | 9.06 | Comparison of norfloxacin with cotrimoxazole for infection prophylaxis in acute leukemia. The trade-off for reduced gram-negative sepsis. ( Bow, EJ; Louie, TJ; Rayner, E, 1988) |
| "Oral trimethoprim-sulfamethoxazole (Bactrim) plus erythromycin (TMZ-E) was tested versus placebo (P) as prophylaxis for bacterial infection in a randomized, double-blind trial in adult cancer patients receiving cytotoxic chemotherapy expected to result in significant neutropenia." | 9.05 | Prophylaxis of fever and infection in adult cancer patients. A placebo-controlled trial of oral trimethoprim-sulfamethoxazole plus erythromycin. ( Carr, DJ; Johnson, A; Kramer, BS; Pizzo, PA; Rand, KH; Robichaud, KJ; Yucha, JB, 1984) |
| "The efficacy of orally administered trimethoprim/sulfamethoxazole for infection prevention following induction chemotherapy was evaluated in 43 patients with acute leukemia." | 9.05 | Oral trimethoprim/sulfamethoxazole in attempt to prevent infection after induction chemotherapy for acute leukemia. ( Arlin, Z; Armstrong, D; Clarkson, B; Gee, T; Henry, SA; Kempin, S, 1984) |
| "We conducted a prospective, controlled, randomized trial of oral trimethoprim-sulfamethoxazole treatment in patients with acute leukemia receiving consolidation chemotherapy." | 9.05 | Prophylactic trimethoprim-sulfamethoxazole during consolidation chemotherapy for acute leukemia: a controlled trial. ( Armstrong, D; Fialk, MA; Lange, M; Singer, C; Szatrowski, TH; Weiser, B, 1981) |
| "The incidence of hematologic abnormalities was evaluated in 120 children with otitis media treated respectively with cotrimoxazole (trimethoprim-sulfamethoxazole) (group 1), cotrimoxazole plus folinic acid (group 2) and amoxicillin (group 3) in therapeutic doses for ten days." | 7.67 | Early and late neutropenia in children treated with cotrimoxazole (trimethoprim-sulfamethoxazole). ( Biasini, A; Biasini, G; Dalla Villa, A; Marchisio, P; Principi, N, 1984) |
| "6 out of 7 patients with severe neutropenia associated with the use of amodiaquine for malaria prophylaxis amodiaquine (400 mg weekly) plus proguanil (200 mg daily); 1 of these patients had also taken cotrimoxazole and another had taken sulphaguanidine." | 7.67 | Frequency of severe neutropenia associated with amodiaquine prophylaxis against malaria. ( Bunch, C; Edwards, G; Hatton, CS; Pasvol, G; Peto, TE; Russell, SJ; Singer, CR; Winstanley, P, 1986) |
| "In patients with AIDS, oral therapy with trimethoprim-sulfamethoxazole and with trimethoprim-dapsone are equally effective for mild-to-moderate first episodes of P." | 6.67 | Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A controlled trial of trimethoprim-sulfamethoxazole versus trimethoprim-dapsone. ( Benowitz, N; Hopewell, PC; Lee, B; Leoung, G; Medina, I; Mills, J; Modin, G; Wofsy, CB, 1990) |
| "A total of 63 neutropenic patients receiving cytotoxic therapy for acute leukemia were randomly allocated to receive norfloxacin (400 mg every 12 hours) or cotrimoxazole (160/800 mg every 12 hours) to prevent bacterial infection." | 5.06 | Comparison of norfloxacin with cotrimoxazole for infection prophylaxis in acute leukemia. The trade-off for reduced gram-negative sepsis. ( Bow, EJ; Louie, TJ; Rayner, E, 1988) |
| "Eighty-four cancer patients at risk of infection because of neutropenia were randomized to receive nalidixic acid as an alternative to trimethoprim-sulfamethoxazole (TMP-SMX) for infection prophylaxis." | 5.06 | Selective gut decontamination with nalidixic acid or trimethoprim-sulfamethoxazole for infection prophylaxis in neutropenic cancer patients: relationship of efficacy to antimicrobial spectrum and timing of administration. ( Bow, EJ; Louie, TJ; Rayner, E; Scott, BA, 1987) |
| "43 patients undergoing treatment for acute leukaemia were randomised to receive either co-trimoxazole alone or co-trimoxazole with framycetin and colistin as antibacterial prophylaxis during periods of neutropenia." | 5.05 | Co-trimoxazole alone for prevention of bacterial infection in patients with acute leukaemia. ( Catovsky, D; Darrell, J; Donnelly, P; Galton, DA; Goldman, JM; Johnson, SA; Starke, ID, 1982) |
| "Of 545 patients expected to develop prolonged neutropenia and randomized to received trimethoprim-sulfamethoxazole (TMP-SMZ) or placebo, 342 were evaluable for occurrence of infection or bacteremia." | 5.05 | Trimethoprim-sulfamethoxazole in the prevention of infection in neutropenic patients. EORTC International Antimicrobial Therapy Project Group. ( , 1984) |
| "Oral trimethoprim-sulfamethoxazole (Bactrim) plus erythromycin (TMZ-E) was tested versus placebo (P) as prophylaxis for bacterial infection in a randomized, double-blind trial in adult cancer patients receiving cytotoxic chemotherapy expected to result in significant neutropenia." | 5.05 | Prophylaxis of fever and infection in adult cancer patients. A placebo-controlled trial of oral trimethoprim-sulfamethoxazole plus erythromycin. ( Carr, DJ; Johnson, A; Kramer, BS; Pizzo, PA; Rand, KH; Robichaud, KJ; Yucha, JB, 1984) |
| "The efficacy of orally administered trimethoprim/sulfamethoxazole for infection prevention following induction chemotherapy was evaluated in 43 patients with acute leukemia." | 5.05 | Oral trimethoprim/sulfamethoxazole in attempt to prevent infection after induction chemotherapy for acute leukemia. ( Arlin, Z; Armstrong, D; Clarkson, B; Gee, T; Henry, SA; Kempin, S, 1984) |
| "We conducted a prospective, controlled, randomized trial of oral trimethoprim-sulfamethoxazole treatment in patients with acute leukemia receiving consolidation chemotherapy." | 5.05 | Prophylactic trimethoprim-sulfamethoxazole during consolidation chemotherapy for acute leukemia: a controlled trial. ( Armstrong, D; Fialk, MA; Lange, M; Singer, C; Szatrowski, TH; Weiser, B, 1981) |
| "The incidence of hematologic abnormalities was evaluated in 120 children with otitis media treated respectively with cotrimoxazole (trimethoprim-sulfamethoxazole) (group 1), cotrimoxazole plus folinic acid (group 2) and amoxicillin (group 3) in therapeutic doses for ten days." | 3.67 | Early and late neutropenia in children treated with cotrimoxazole (trimethoprim-sulfamethoxazole). ( Biasini, A; Biasini, G; Dalla Villa, A; Marchisio, P; Principi, N, 1984) |
| "6 out of 7 patients with severe neutropenia associated with the use of amodiaquine for malaria prophylaxis amodiaquine (400 mg weekly) plus proguanil (200 mg daily); 1 of these patients had also taken cotrimoxazole and another had taken sulphaguanidine." | 3.67 | Frequency of severe neutropenia associated with amodiaquine prophylaxis against malaria. ( Bunch, C; Edwards, G; Hatton, CS; Pasvol, G; Peto, TE; Russell, SJ; Singer, CR; Winstanley, P, 1986) |
| "In patients with AIDS, oral therapy with trimethoprim-sulfamethoxazole and with trimethoprim-dapsone are equally effective for mild-to-moderate first episodes of P." | 2.67 | Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A controlled trial of trimethoprim-sulfamethoxazole versus trimethoprim-dapsone. ( Benowitz, N; Hopewell, PC; Lee, B; Leoung, G; Medina, I; Mills, J; Modin, G; Wofsy, CB, 1990) |
| "Norfloxacin has been compared to placebo (136 patients), sulfamethoxazole plus trimethoprim (SXT, 72 patients) and oral vancomycin plus colistin (V/C, 61 patients) for the prevention of alimentary tract-associated infections during and after induction chemotherapy." | 2.66 | The tolerability profile of prophylactic norfloxacin in neutropenic patients. ( Corrado, ML; Hesney, M; Struble, WE, 1988) |
| "Ketoconazole or miconazole was randomly administered to 42 and 46 neutropenic patients respectively." | 2.65 | Oral prophylaxis with miconazole or ketoconazole of invasive fungal disease in neutropenic cancer patients. ( Cruciani, M; Klastersky, J; Meunier-Carpentier, F, 1983) |
| "One hundred children with cancer and bacterial sepsis were observed for one month after completion of antibiotic treatment for subsequent episodes of infection." | 1.27 | Post-sepsis prophylaxis in cancer patients. ( Hughes, WT; Patterson, G, 1984) |
| "Thrombocytopenia was noted between the seventh and 16th day (mean, 10." | 1.26 | Hematologic abnormalities after oral trimethoprim-sulfamethoxazole therapy in children. ( Asmar, BI; Dajani, AS; Maqbool, S, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 44 (89.80) | 18.7374 |
| 1990's | 3 (6.12) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (4.08) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vinker-Shuster, M | 1 |
| Stepensky, P | 1 |
| Temper, V | 1 |
| Shayovitz, V | 1 |
| Masarwa, R | 1 |
| Averbuch, D | 1 |
| Maschmeyer, G | 1 |
| Carratalà, J | 1 |
| Buchheidt, D | 1 |
| Hamprecht, A | 1 |
| Heussel, CP | 1 |
| Kahl, C | 1 |
| Lorenz, J | 1 |
| Neumann, S | 1 |
| Rieger, C | 1 |
| Ruhnke, M | 1 |
| Salwender, H | 1 |
| Schmidt-Hieber, M | 1 |
| Azoulay, E | 1 |
| Starke, ID | 1 |
| Donnelly, P | 1 |
| Catovsky, D | 2 |
| Darrell, J | 2 |
| Johnson, SA | 1 |
| Goldman, JM | 2 |
| Galton, DA | 2 |
| Meunier-Carpentier, F | 2 |
| Cruciani, M | 1 |
| Klastersky, J | 2 |
| Principi, N | 1 |
| Marchisio, P | 1 |
| Biasini, A | 1 |
| Dalla Villa, A | 1 |
| Biasini, G | 1 |
| Riben, PD | 1 |
| Louie, TJ | 3 |
| Lank, BA | 1 |
| Kornachuk, E | 1 |
| Gurwith, MJ | 1 |
| Harding, GK | 1 |
| Ronald, AR | 1 |
| Zinner, SH | 1 |
| Leahy, MF | 1 |
| Humble, MW | 1 |
| Wolff, LJ | 1 |
| Kramer, BS | 1 |
| Carr, DJ | 1 |
| Rand, KH | 1 |
| Pizzo, PA | 1 |
| Johnson, A | 1 |
| Robichaud, KJ | 1 |
| Yucha, JB | 1 |
| Henry, SA | 1 |
| Armstrong, D | 2 |
| Kempin, S | 1 |
| Gee, T | 1 |
| Arlin, Z | 1 |
| Clarkson, B | 1 |
| Hughes, WT | 1 |
| Patterson, G | 1 |
| Scaglione, C | 1 |
| Tormena, AM | 1 |
| Pavlovsky, S | 1 |
| Kauffman, CA | 1 |
| Liepman, MK | 1 |
| Bergman, AG | 1 |
| Mioduszewski, J | 1 |
| Beutler, SM | 1 |
| Barth, NM | 1 |
| Bayer, AS | 1 |
| Rubin, RH | 1 |
| Swartz, MN | 1 |
| Ekert, H | 1 |
| Jurk, IH | 1 |
| Waters, KD | 1 |
| Tiedemann, K | 1 |
| Lanzkowsky, P | 1 |
| Schaeffer, J | 1 |
| Bradley, PP | 1 |
| Warden, GD | 1 |
| Maxwell, JG | 1 |
| Rothstein, G | 1 |
| Weiser, B | 1 |
| Lange, M | 1 |
| Fialk, MA | 1 |
| Singer, C | 1 |
| Szatrowski, TH | 1 |
| Malarme, M | 1 |
| Guess, HA | 1 |
| Cohen, MS | 1 |
| Stockman, JA | 1 |
| Asmar, BI | 1 |
| Maqbool, S | 1 |
| Dajani, AS | 1 |
| Giamarellou, H | 1 |
| Hawkins, T | 1 |
| Carter, JM | 1 |
| Romeril, KR | 1 |
| Jackson, SR | 1 |
| Green, GJ | 1 |
| Enno, A | 1 |
| Hows, J | 1 |
| Bateman, CJ | 1 |
| Geddes, AM | 1 |
| Ball, AP | 1 |
| Farrell, ID | 1 |
| Marty, M | 1 |
| Gisselbrecht, C | 1 |
| Samson-Lepors, MJ | 1 |
| Melikian, V | 1 |
| Falk, R | 1 |
| Shah, CP | 1 |
| Sanghavi, NG | 1 |
| Amin, VC | 1 |
| Medina, I | 1 |
| Mills, J | 1 |
| Leoung, G | 1 |
| Hopewell, PC | 1 |
| Lee, B | 1 |
| Modin, G | 1 |
| Benowitz, N | 1 |
| Wofsy, CB | 1 |
| Hatton, CS | 1 |
| Peto, TE | 1 |
| Bunch, C | 1 |
| Pasvol, G | 1 |
| Russell, SJ | 1 |
| Singer, CR | 1 |
| Edwards, G | 1 |
| Winstanley, P | 1 |
| Figueredo, AT | 1 |
| Hryniuk, WM | 1 |
| Strautmanis, I | 1 |
| Frank, G | 1 |
| Rendell, S | 1 |
| Koletzko, B | 1 |
| Wendel, U | 1 |
| Bremer, HJ | 1 |
| Verhoef, J | 1 |
| Rozenberg-Arska, M | 1 |
| Dekker, A | 1 |
| De Pauw, BE | 1 |
| Novakova, IR | 1 |
| Ubachs, E | 1 |
| Hoes, A | 1 |
| Stalpers, L | 1 |
| Verhagen, C | 1 |
| Corrado, ML | 1 |
| Struble, WE | 1 |
| Hesney, M | 1 |
| Bow, EJ | 2 |
| Rayner, E | 2 |
| Scott, BA | 1 |
| Wells, CL | 1 |
| Ferrieri, P | 1 |
| Weisdorf, DJ | 1 |
| Rhame, FS | 1 |
| Harris, GJ | 1 |
| Franson, TR | 1 |
| Unowsky, J | 1 |
| Chandrasekar, PH | 1 |
| DeLorenzo, W | 1 |
| Levine, DP | 1 |
| Riou, B | 2 |
| Richard, C | 2 |
| Rimailho, A | 2 |
| Auzepy, P | 2 |
| Coquin, Y | 1 |
| Rottman, E | 1 |
| Gordon-Smith, EC | 1 |
| Spiers, AS | 1 |
| Tattersall, MH | 1 |
| Gaya, H | 1 |
3 reviews available for trimethoprim and Neutropenia
| Article | Year |
|---|---|
Supportive care for children with cancer. Guidelines of the Childrens Cancer Study Group. Use of prophylactic antibiotics.
Topics: Adolescent; Adult; Amphotericin B; Anti-Bacterial Agents; Bacterial Infections; Candidiasis; Child; | 1984 |
Empiric therapy for infections in the febrile, neutropenic, compromised host.
Topics: Algorithms; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Clinical Trials as Topic; | 1995 |
Co-trimoxazole for the treatment of serious infections.
Topics: Bacterial Infections; Brucellosis; Carrier State; Drug Combinations; Humans; Intestinal Diseases; Ma | 1979 |
20 trials available for trimethoprim and Neutropenia
| Article | Year |
|---|---|
Gram-negative Bacteremia in Children With Hematologic Malignancies and Following Hematopoietic Stem Cell Transplantation: Epidemiology, Resistance, and Outcome.
Topics: Adolescent; Allografts; Bacteremia; Child; Child, Preschool; Drug Combinations; Drug Resistance, Bac | 2019 |
Co-trimoxazole alone for prevention of bacterial infection in patients with acute leukaemia.
Topics: Acute Disease; Adult; Aged; Bacterial Infections; Clinical Trials as Topic; Colistin; Drug Combinati | 1982 |
Oral prophylaxis with miconazole or ketoconazole of invasive fungal disease in neutropenic cancer patients.
Topics: Agranulocytosis; Antifungal Agents; Candidiasis; Drug Combinations; Female; Humans; Imidazoles; Keto | 1983 |
Reduction in mortality from gram-negative sepsis in neutropenic patients receiving trimethoprim/sulfamethoxazole therapy.
Topics: Adult; Aged; Agranulocytosis; Bacterial Infections; Clinical Trials as Topic; Female; Humans; Leukem | 1983 |
Prophylaxis of bacterial infections with oral antibiotics in neutropenic patients. Lessons from the last two EORTC trials and prospects for the future.
Topics: Administration, Oral; Agranulocytosis; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; | 1983 |
Trimethoprim-sulfamethoxazole in the prevention of infection in neutropenic patients. EORTC International Antimicrobial Therapy Project Group.
Topics: Agranulocytosis; Anti-Bacterial Agents; Bacterial Infections; Clinical Trials as Topic; Drug Combina | 1984 |
Prophylaxis of fever and infection in adult cancer patients. A placebo-controlled trial of oral trimethoprim-sulfamethoxazole plus erythromycin.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; D | 1984 |
Oral trimethoprim/sulfamethoxazole in attempt to prevent infection after induction chemotherapy for acute leukemia.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Antineoplastic Agents; Drug Combinations; Dr | 1984 |
[Prophylactic controlled trials with cotrimoxazole in afebrile neutropenic patients with malignant hemopathies].
Topics: Adult; Agranulocytosis; Child; Clinical Trials as Topic; Drug Combinations; Fever; Humans; Infection | 1982 |
Trimethoprim/sulfamethoxazole prophylaxis in neutropenic patients. Reduction of infections and effect on bacterial and fungal flora.
Topics: Adult; Aged; Agranulocytosis; Antineoplastic Agents; Bacteria; Bacterial Infections; Drug Resistance | 1983 |
Prophylactic co-trimoxazole and lactobacilli preparation in neutropenic patients.
Topics: Agranulocytosis; Anti-Bacterial Agents; Antifungal Agents; Bacterial Infections; Biological Products | 1980 |
Prophylactic trimethoprim-sulfamethoxazole during consolidation chemotherapy for acute leukemia: a controlled trial.
Topics: Acute Disease; Adult; Aged; Antineoplastic Agents; Bacterial Infections; Clinical Trials as Topic; D | 1981 |
Vancomycin plus gentamicin and cotrimoxazole for prevention of infections in neutropenic cancer patients (a comparative, placebo-controlled pilot study).
Topics: Adult; Agranulocytosis; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Clinical | 1981 |
Co-trimoxazole for prevention of infection in acute leukaemia.
Topics: Administration, Oral; Adolescent; Adult; Aged; Clinical Trials as Topic; Colistin; Cross Infection; | 1978 |
Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A controlled trial of trimethoprim-sulfamethoxazole versus trimethoprim-dapsone.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Chemical and Drug Induced Liver Inj | 1990 |
Co-trimoxazole prophylaxis during high-dose chemotherapy of small-cell lung cancer.
Topics: Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cats; Cisplati | 1985 |
Prevention of infection in patients with acute nonlymphocytic leukemia by several drug treatment regimens.
Topics: Acute Disease; Adult; Anti-Infective Agents; Ciprofloxacin; Clinical Trials as Topic; Colistin; Drug | 1987 |
The tolerability profile of prophylactic norfloxacin in neutropenic patients.
Topics: Agranulocytosis; Bacterial Infections; Clinical Trials as Topic; Colistin; Diarrhea; Gastrointestina | 1988 |
Comparison of norfloxacin with cotrimoxazole for infection prophylaxis in acute leukemia. The trade-off for reduced gram-negative sepsis.
Topics: Acute Disease; Adult; Antineoplastic Agents; Bacterial Infections; Clinical Trials as Topic; Drug Co | 1988 |
Selective gut decontamination with nalidixic acid or trimethoprim-sulfamethoxazole for infection prophylaxis in neutropenic cancer patients: relationship of efficacy to antimicrobial spectrum and timing of administration.
Topics: Agranulocytosis; Antineoplastic Agents; Bacteria; Bacterial Infections; Clinical Trials as Topic; Dr | 1987 |
26 other studies available for trimethoprim and Neutropenia
| Article | Year |
|---|---|
Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients (allogeneic SCT excluded): updated guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).
Topics: Anti-Infective Agents; Bronchoalveolar Lavage Fluid; Drug Combinations; Fever; Humans; Lung; Lung Di | 2015 |
Early and late neutropenia in children treated with cotrimoxazole (trimethoprim-sulfamethoxazole).
Topics: Agranulocytosis; Amoxicillin; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; | 1984 |
Outbreak of co-trimoxazole- and gentamicin-resistant Klebsiella aerogenes bacteremia in neutropenic patients receiving oral co-trimoxazole prophylaxis.
Topics: Aged; Drug Combinations; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Gentamicins; | 1983 |
Post-sepsis prophylaxis in cancer patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Child; Drug Therapy, Combinati | 1984 |
Preventing infection in neutropenic cancer patients.
Topics: Agranulocytosis; Bacterial Infections; Humans; Immunosuppression Therapy; Leukemia; Neutropenia; Sul | 1983 |
Trimethoprim-sulfamethoxazole.
Topics: Administration, Oral; Adult; Bacteria; Child; Drug Combinations; Drug Interactions; Drug Resistance, | 1980 |
Prophylactic use of TMP-SMZ in leukemia.
Topics: Agranulocytosis; Child; Drug Combinations; Humans; Leukemia, Lymphoid; Neutropenia; Pulmonary Fibros | 1982 |
Neutropenia and thrombocytopenia in renal allograft recipients treated with trimethoprim-sulfamethoxazole.
Topics: Adult; Agranulocytosis; Azathioprine; Bone Marrow; Drug Combinations; Drug Synergism; Humans; Kidney | 1980 |
Drug treatment of otitis media and urinary tract infections.
Topics: Agranulocytosis; Child; Humans; Neutropenia; Otitis Media; Sulfamethoxazole; Thrombocytopenia; Trime | 1982 |
Trimethoprim-sulfamethoxazole therapy. Everything's not turning up roses.
Topics: Bacterial Infections; Child; Drug Combinations; Humans; Neutropenia; Sulfamethoxazole; Thrombocytope | 1981 |
Hematologic abnormalities after oral trimethoprim-sulfamethoxazole therapy in children.
Topics: Amoxicillin; Anemia; Blood; Child; Child, Preschool; Drug Therapy, Combination; Eosinophilia; Female | 1981 |
Severe trimethoprim induced neutropenia and thrombocytopenia.
Topics: Adult; Aged; Aged, 80 and over; Female; Humans; Neutropenia; Thrombocytopenia; Trimethoprim | 1993 |
Prophylactic co-trimoxazole in leukaemia.
Topics: Drug Combinations; Humans; Infection Control; Leukemia, Myeloid, Acute; Neutropenia; Sulfamethoxazol | 1978 |
[Treatment of febrile episodes in the neutropenic subject: use of the combination of amikacin-colistin-trimethoprim-sulphamethoxazole].
Topics: Agranulocytosis; Amikacin; Colistin; Drug Therapy, Combination; Fever; Humans; Kanamycin; Neutropeni | 1979 |
Treatment of febrile episodes in neutropenic patients.
Topics: Agranulocytosis; Anti-Bacterial Agents; Clindamycin; Drug Combinations; Fever; Humans; Immunosuppres | 1976 |
Efficacy and toxicity of trimethoprimsulfamethoxazole in typhoid fever.
Topics: Adolescent; Adult; Child; Chloramphenicol; Drug Combinations; Humans; Neutropenia; Sulfamethoxazole; | 1975 |
Frequency of severe neutropenia associated with amodiaquine prophylaxis against malaria.
Topics: Acute Disease; Adult; Agranulocytosis; Amodiaquine; Drug Combinations; Drug Therapy, Combination; Fe | 1986 |
Lithium for treatment of neutropenia in glycogen storage disease type Ib.
Topics: Agranulocytosis; Chlorides; Drug Combinations; Drug Therapy, Combination; Female; Glycogen Storage D | 1986 |
Co-trimoxazole in patients with haematological malignancies: a review of 10-years' clinical experience.
Topics: Anti-Infective Agents; Drug Combinations; Humans; Intestines; Leukemia; Neutropenia; Opportunistic I | 1988 |
The importance of surveillance stool cultures during periods of severe neutropenia.
Topics: Adult; Agranulocytosis; Anti-Bacterial Agents; Bone Marrow Transplantation; Child; Drug Combinations | 1987 |
Neutropenia induced by short-term oral trimethoprim-sulfamethoxazole therapy; case report.
Topics: Adult; Agranulocytosis; Anti-Infective Agents, Urinary; Drug Combinations; Female; Humans; Neutropen | 1986 |
In vitro and in vivo activity of coumermycin and other antibacterial agents against methicillin-resistant strains of Staphylococcus aureus.
Topics: Aminocoumarins; Animals; Anti-Bacterial Agents; Coumarins; Drug Combinations; Female; Fusidic Acid; | 1986 |
Potential risks of trimethoprim-sulfamethoxazole prophylaxis in neutropenic patients.
Topics: Agranulocytosis; Drug Combinations; Drug Resistance, Microbial; Humans; Neutropenia; Risk; Sulfameth | 1985 |
[Antibiotic resistance of Escherichia coli. Importance of the resistance to trimethoprim-sulfamethoxazole].
Topics: Anti-Bacterial Agents; Bacterial Infections; Drug Combinations; Drug Resistance, Microbial; Escheric | 1985 |
Treatment of aplastic anemias.
Topics: Adult; Anemia, Aplastic; Anti-Bacterial Agents; Antifungal Agents; Antilymphocyte Serum; Bone Marrow | 1985 |
Indications for systemic antibiotic prophylaxis in neutropenic patients.
Topics: Adult; Agranulocytosis; Anti-Bacterial Agents; Biguanides; Blood Cell Count; Carbenicillin; Cephalot | 1974 |